Company intelligence / Profile preview

Mendel

San Jose, California, United Statesmendel.ai ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Mendel provides an advanced artificial intelligence platform designed to extract insights from structured and unstructured clinical data at scale. Its neuro-symbolic AI outperforms standard LLMs in precision and recall for tasks like patient cohort identification. The company’s solutions are validated in real-world settings with leading life sciences customers, enabling faster, more accurate clinical trial matching, data abstraction/OCR, PHI de-identification, and analytics. Their technology has been shown to reduce manual labor costs dramatically while maintaining high compliance standards such as HIPAA.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Mendel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mendel.

Explore the full profile